Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems Inc's Device Gets Nod To Treat Heart Calcium Deposits-Reuters


Tuesday, 22 Oct 2013 11:21am EDT 

Reuters reported that Cardiovascular Systems Inc said it received the U.S. health regulator's approval to market its heart device to treat severe accumulation of calcium in coronary arteries, sending its shares up. The device, Diamondback 360 Coronary Orbital Atherectomy System, will be launched immediatel. Plaque build up, including calcium deposits, in arteries reduces blood supply to the heart, leading to coronary artery disease. 

Company Quote

27.93
-0.41 -1.45%
22 May 2015